NCT07506252

Brief Summary

Due to the current lack of evidence regarding the influence of fluid intake on the amount of leukocyte- and platelet-rich fibrin fraction present in blood samples, this study aims to investigate the positive influence of this factor on the body's own matrix. Platelet-rich fibrin, a fibrin-rich autologous matrix obtained from autologous blood via centrifugation, contains not only fibrin but also important growth factors and a large number of white blood cells, all of which make a significant contribution to tissue regeneration. The obtained fibrin matrix can be used as a membrane, as a clot (A-PRF), or as a liquid (i-PRF) to positively influence the healing process. The novelty of this work lies in shifting the focus from purely technical centrifugation parameters to a patient-centered, easily modifiable biological variable. Hydration status represents a low-cost, non-invasive, and immediately applicable strategy to optimize autologous blood concentrates. These findings are directly relevant to clinicians seeking to enhance the predictability and efficiency of PRF-based regenerative procedures in implant dentistry.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2023

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

March 17, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 1, 2026

Completed
Last Updated

April 1, 2026

Status Verified

March 1, 2026

Enrollment Period

5 months

First QC Date

March 17, 2026

Last Update Submit

March 27, 2026

Conditions

Keywords

PRFHydrationimplant dentistryregenerative dentistry

Outcome Measures

Primary Outcomes (1)

  • PRF-Volume

    Volume (ml) of i-PRF obtained from each 10 ml blood sample with low speed centrifugation

    3 visits, 3 weeks

Secondary Outcomes (2)

  • PRF yield and height

    3 visits, 3 weeks

  • PRF yield and weight

    3 visits, 3 weeks

Study Arms (1)

Hydration

EXPERIMENTAL

Drinking protocol to reach euhydration

Behavioral: Hydration following a drinking protocol

Interventions

Participants followed a drinking protocol the day before the measurement to reach euhydration

Hydration

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Healthy adults

You may not qualify if:

  • coagulation disorders
  • anticoagulant medication
  • pregnancy
  • acute infections
  • systemic diseases with the potential to affect wound healing or blood composition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Graz

Graz, Styria, 8010, Austria

Location

Related Publications (2)

  • Verboket RD, Anbar B, Sohling N, Kontradowitz K, Marzi I, Ghanaati S, Henrich D. Changes in platelet-rich fibrin composition after trauma and surgical intervention. Platelets. 2020 Nov 16;31(8):1069-1079. doi: 10.1080/09537104.2020.1714575. Epub 2020 Jan 23.

    PMID: 31971046BACKGROUND
  • Hauser F, Gaydarov N, Badoud I, Vazquez L, Bernard JP, Ammann P. Clinical and histological evaluation of postextraction platelet-rich fibrin socket filling: a prospective randomized controlled study. Implant Dent. 2013 Jun;22(3):295-303. doi: 10.1097/ID.0b013e3182906eb3.

    PMID: 23644909BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2026

First Posted

April 1, 2026

Study Start

December 12, 2022

Primary Completion

May 19, 2023

Study Completion

May 19, 2023

Last Updated

April 1, 2026

Record last verified: 2026-03

Locations